LVL Medical Group

LVL Medical Group was a French home healthcare services company focused on delivering and managing care for patients in the home setting rather than developing therapeutics. Its core activities included respiratory assistance, home infusion, enteral nutrition, and insulin pump therapy, along with the supply, installation, and maintenance of medical equipment used for home treatment. The company served tens of thousands of patients in France and historically expanded through a network of agencies and selected acquisitions. In 2012, Air Liquide acquired control of LVL Medical's French activities through a public tender process, and the company was subsequently delisted and later dissolved/radiated as a standalone corporate entity. For a biotech analyst, this is best understood as a commercial homecare and medical services company, not a drug-development biotech or pharma company.